Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

SIMPLE SUMMARY: Tyrosine kinase inhibitor (TKI) therapy is often taken indefinitely by chronic myeloid leukemia (CML) patients. However, little is known about the long-term or under-reported TKI side effects due to limited longitudinal clinical data on these relatively new drugs. We utilize novel cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehra, Nidhi, Varmeziar, Armon, Chen, Xinyu, Kronick, Olivia, Fisher, Rachel, Kota, Vamsi, Mitchell, Cassie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563938/
https://www.ncbi.nlm.nih.gov/pubmed/36230609
http://dx.doi.org/10.3390/cancers14194686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563938/
https://www.ncbi.nlm.nih.gov/pubmed/36230609
http://dx.doi.org/10.3390/cancers14194686

Ejemplares similares